Skip to main content
OpenTrials
Completed

NCT Number: NCT00095810

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Parkinson's Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Mental Disorders Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinson Disease Parkinsonian Disorders Psychoses Psychotic Disorders Schizophrenia Spectrum and Other Psychotic Disorders Synucleinopathies

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Local Institution

Albany, New York, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary diagnosis of idiopathic Parkinson's disease.
  • Psychosis related to Parkinson's disease.

Exclusion criteria

  • Psychosis present prior to diagnosis of Parkinson's disease.

Treatment and study plan

Aripiprazole

Drug

Tablets, Oral, 1-10mg, Once daily, 6 weeks.

Other names: Abilify

Primary outcomes

  1. Tolerability

Secondary outcomes

  1. Safety Assessments

Sponsors and collaborators

Lead sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Industry

Collaborators

  • Otsuka America Pharmaceutical

Registry information

Official study title

An Open-Label Study of Aripiprazole to Evaluate the Safety and Tolerability in Patients With Psychosis Associated With Parkinson's Disease

Important dates

Study start
2003
Primary completion
2004
Study completion
2004
First posted
Nov 9, 2004
Registry last updated
Nov 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.